Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease.

No Thumbnail Available

Date

2019

Journal Title

Journal ISSN

Volume Title

Publisher

American College of Gastroenterology

Abstract

Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-α therapy

Description

Not indexed in MEDLINE. ESCI

Keywords

Crohn's disease

Citation

ACG Case Reports Journal.2019;6(6):e00075

Endorsement

Review

Supplemented By

Referenced By